Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce Cramer

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Alcoholism, Clinical and Experimental Research|December 12, 2007
Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism"John H Krystal, Ralitza Gueorguieva, Joyce Cramer, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|March 10, 2010
The evolution of antiepileptic drug development and regulationAlexis Arzimanoglou, Elinor Ben-Menachem, Joyce Cramer, et al.
Pharmacogenetics and Genomics|April 17, 2009
The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variationLingjun Zuo, Xingguang Luo, John H Krystal, et al.
Journal of the American Geriatrics Society|February 14, 2004
Potentially inappropriate antiepileptic drugs for elderly patients with epilepsyMary Jo V Pugh, Joyce Cramer, Janice Knoefel, et al.
Alcoholism, Clinical and Experimental Research|March 22, 2007
Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative StudyJoel Gelernter, Ralitza Gueorguieva, Henry R Kranzler, et al.
Biological Psychiatry|January 17, 2007
New insights into the efficacy of naltrexone based on trajectory-based reanalyses of two negative clinical trialsRalitza Gueorguieva, Ran Wu, Brian Pittman, et al.
AIDS Patient Care and Stds|February 1, 2007
Improved adherence with contingency managementMarc I Rosen, Kevin Dieckhaus, Thomas J McMahon, et al.
Epilepsy & Behavior : E&B|September 2, 2009
Conversations between community-based neurologists and patients with epilepsy: results of an observational linguistic studyFrank Gilliam, Patricia E Penovich, Corey A Eagan, et al.
Hypertension (Dallas, Tex. : 1979)|May 3, 2006
Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective dataMichael T Halpern, Zeba M Khan, Jordana K Schmier, et al.
Archives of General Psychiatry|September 7, 2002
A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United StatesJaakko Lappalainen, Henry R Kranzler, Robert Malison, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Alcoholism, Clinical and Experimental Research|December 12, 2007
Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism"John H Krystal, Ralitza Gueorguieva, Joyce Cramer, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|March 10, 2010
The evolution of antiepileptic drug development and regulationAlexis Arzimanoglou, Elinor Ben-Menachem, Joyce Cramer, et al.
Pharmacogenetics and Genomics|April 17, 2009
The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variationLingjun Zuo, Xingguang Luo, John H Krystal, et al.
Journal of the American Geriatrics Society|February 14, 2004
Potentially inappropriate antiepileptic drugs for elderly patients with epilepsyMary Jo V Pugh, Joyce Cramer, Janice Knoefel, et al.
Alcoholism, Clinical and Experimental Research|March 22, 2007
Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative StudyJoel Gelernter, Ralitza Gueorguieva, Henry R Kranzler, et al.
Biological Psychiatry|January 17, 2007
New insights into the efficacy of naltrexone based on trajectory-based reanalyses of two negative clinical trialsRalitza Gueorguieva, Ran Wu, Brian Pittman, et al.
AIDS Patient Care and Stds|February 1, 2007
Improved adherence with contingency managementMarc I Rosen, Kevin Dieckhaus, Thomas J McMahon, et al.
Epilepsy & Behavior : E&B|September 2, 2009
Conversations between community-based neurologists and patients with epilepsy: results of an observational linguistic studyFrank Gilliam, Patricia E Penovich, Corey A Eagan, et al.
Hypertension (Dallas, Tex. : 1979)|May 3, 2006
Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective dataMichael T Halpern, Zeba M Khan, Jordana K Schmier, et al.
Archives of General Psychiatry|September 7, 2002
A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United StatesJaakko Lappalainen, Henry R Kranzler, Robert Malison, et al.
Pageof 3